New York, NY, United States of America

Brent R Stockwell

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 201(Granted Patents)


Location History:

  • Boston, MA (US) (2002 - 2006)
  • New York, NY (US) (2008 - 2021)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Brent R. Stockwell: Innovator in Neurodegenerative Disease Research

Introduction

Brent R. Stockwell is a notable inventor based in New York, NY, with an impressive portfolio of 24 patents. His work primarily focuses on developing therapeutic compounds aimed at addressing challenges related to toxic stress in cells and neurodegenerative diseases. Through his innovative research, he seeks to make significant contributions to the fields of pharmacology and molecular medicine.

Latest Patents

Among Stockwell's latest patents is the invention titled "Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum stress." This invention provides compounds designed to mitigate the toxicity from endoplasmic reticulum (ER) stress, along with compositions for medical treatments. Additionally, he has patented methods for treating disorders and neurodegenerative diseases linked to axon degeneration.

Another significant patent is for "Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders." This patent introduces a compound structure aimed at modulating ferroptosis—a type of regulated cell death—and reducing reactive oxygen species (ROS) in cells, crucial for treating excitotoxic disorders and neurodegenerative conditions.

Career Highlights

Brent R. Stockwell has held prestigious positions at renowned institutions such as Columbia University in the City of New York, where he has contributed significantly to research efforts in pharmacology and biotechnology. Additionally, he worked with Combinatorx, Incorporated, where his insights into drug development led to innovative therapeutic solutions.

Collaborations

Throughout his career, Stockwell has collaborated with several notable researchers, including Rachid Skouta and Scott E. Dixon. These collaborations have facilitated cross-disciplinary approaches to tackling complex medical challenges, enhancing the impact of their combined research efforts.

Conclusion

Brent R. Stockwell's innovative spirit and dedicated research efforts in the field of neurodegenerative disease treatment underscore his importance as an inventor. His patents exemplify forward-thinking advancements in medicinal chemistry, paving the way for future research and potential therapies that could significantly improve patient outcomes in the face of neurodegenerative conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…